A top cardiologist has revealed the recreational drugs he would never use because they could damage your heart and kill you. Dr Siyab Panhwar, a cardiologist at NYU Langone in New York City ...

In America, heart disease is the No. 1 killer of men and women and the leading cause of death for people of most racial and ethnic groups.

Using a most cost-effective drug to treat some of the most common and dangerous heart conditions could save the NHS a ...

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

And despite its newness to gynecologic oncology, it is a familiar pharmaceutical that has been in use as an approved drug since the mid-1990s for acute heart failure. Cancer biologists hope to ...

Stifel analyst James Condulis writes Cytokinetics’ aficamten is an exceptional drug as it sets a strong competitive standard for a multi-billion-dollar obstructive hypertrophic cardiomyopathy ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure. This was ...

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...